Channel Therapeutics Corporation - CHRO

SEC FilingsOur CHRO Tweets

About Gravity Analytica

Recent News

  • 11.04.2025 - Pete Blackhurst, International SaaS Revenue Leader, Joins VisitIQ™ as Chief Revenue Officer
  • 09.24.2025 - Upcoming Webcast: Targeting 2.0 – Using AI to Build Better Audiences
  • 09.17.2025 - Smarter ICPs Start Here: How Agencies Use AI to Unlock Real Results
  • 09.16.2025 - Lookalike Audiences That Work: Why AI Gives Agencies an Unfair Advantage
  • 09.08.2025 - Pelthos Therapeutics to Participate in Upcoming September Investor Conferences
  • 09.02.2025 - Pelthos Therapeutics to Participate in the 2025 Wells Fargo Healthcare Conference
  • 08.18.2025 - Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update

Recent Filings

  • 10.14.2025 - 8-K Current report
  • 10.14.2025 - EX-99.1 EX-99.1
  • 09.29.2025 - 424B3 Prospectus [Rule 424(b)(3)]
  • 09.24.2025 - EFFECT Notice of Effectiveness
  • 09.19.2025 - S-3/A Registration statement under Securities Act of 1933
  • 09.16.2025 - 8-K/A Current report
  • 09.03.2025 - EX-99.1 EX-99.1
  • 09.03.2025 - 8-K Current report
  • 08.28.2025 - S-3 Registration statement under Securities Act of 1933
  • 08.18.2025 - 8-K Current report